Background: Not all morbidly obese patients want, or are eligible for bariatric surgery, and therefore depend on effective lifestyle interventions. Purpose: This study aimed to compare changes in body weight (BW), risk factors and comorbidities 5 years after Roux-en-Y gastric bypass (RYGB) or three lifestyle interventions in morbidly obese patients. Methods: 209 (75.1% women) morbidly obese adult (mean (standard deviation (SD)): age 40.9 years (9.5), BW 133.4 kg (19.6), body mass index (BMI) of 45.4 kg/m 2 (5.6)) patients were non-randomly allocated to: A) laparoscopic RYGB (n = 58), B) weight loss (WL) camp (n = 30), C) residential intermittent program (n = 64), or D) hospital outpatient program (n = 57). BW, ...
BACKGROUND: There is no consensus on the ideal bariatric operation to choose for patients with extre...
Background: Despite the extensive literature on the outcome and impact of Roux-en-Y gastric bypass (...
This review focuses on the most effective treatment modalities for reducing cardiovascular risk fact...
Changes in body weight (BW), risk factors and comorbidities 5 years after Roux-en-Y gastric bypass (...
Introduction: The American Society of Metabolic and Bariatric Surgery (ASMBS) and the International ...
Background: The epidemic of obesity threatens the health of millions of people. When uncontrolled, o...
OBJECTIVE:: To evaluate effect on comorbid disease and weight loss 5 years after Roux-en-Y gastric b...
Obesity is associated with increased morbidity and mortality. A BMI >40 kg/m2 shortens life expec...
Background Bariatric surgery particularly benefits patients with obesity-related comorbidities such ...
HYPOTHESIS: Gastric banding (GB) and Roux-en-Y gastric bypass (RYGBP) are used in the treatment of m...
Objectives: Morbid obesity is often accompanied by several comorbid diseases which reduce lifespan a...
Background: There is little robust evidence relating to changes in health related quality of life (H...
Introduction: A considerable number of patients experience some long-term weight regain after bariat...
Background: While Roux-en-Y gastric bypass (RYGB) is effective in achieving weight loss and improvin...
BACKGROUND: There is no consensus on the ideal bariatric operation to choose for patients with extre...
Background: Despite the extensive literature on the outcome and impact of Roux-en-Y gastric bypass (...
This review focuses on the most effective treatment modalities for reducing cardiovascular risk fact...
Changes in body weight (BW), risk factors and comorbidities 5 years after Roux-en-Y gastric bypass (...
Introduction: The American Society of Metabolic and Bariatric Surgery (ASMBS) and the International ...
Background: The epidemic of obesity threatens the health of millions of people. When uncontrolled, o...
OBJECTIVE:: To evaluate effect on comorbid disease and weight loss 5 years after Roux-en-Y gastric b...
Obesity is associated with increased morbidity and mortality. A BMI >40 kg/m2 shortens life expec...
Background Bariatric surgery particularly benefits patients with obesity-related comorbidities such ...
HYPOTHESIS: Gastric banding (GB) and Roux-en-Y gastric bypass (RYGBP) are used in the treatment of m...
Objectives: Morbid obesity is often accompanied by several comorbid diseases which reduce lifespan a...
Background: There is little robust evidence relating to changes in health related quality of life (H...
Introduction: A considerable number of patients experience some long-term weight regain after bariat...
Background: While Roux-en-Y gastric bypass (RYGB) is effective in achieving weight loss and improvin...
BACKGROUND: There is no consensus on the ideal bariatric operation to choose for patients with extre...
Background: Despite the extensive literature on the outcome and impact of Roux-en-Y gastric bypass (...
This review focuses on the most effective treatment modalities for reducing cardiovascular risk fact...